Anzeige
Mehr »
Login
Mittwoch, 04.10.2023 Börsentäglich über 12.000 News von 676 internationalen Medien
TDDE Tipp: Die Signale beachten und heute handeln…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PDK8 | ISIN: US81577F1093 | Ticker-Symbol: NXEN
Tradegate
02.10.23
21:25 Uhr
0,190 Euro
-0,006
-3,12 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
SEELOS THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
SEELOS THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,1860,18903.10.
0,0000,00003.10.

Aktuelle News zur SEELOS THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoSEELOS THERAPEUTICS, INC. - 8-K, Current Report2
27.09.Seelos Therapeutics' Aggressive Alzheimer's Hopeful Candidate Shows Encouraging Preclinical Activity5
27.09.Seelos Announces Encouraging Data From Study Of SLS-005 In Preclinical Model Of Alzheimer's Disease286WASHINGTON (dpa-AFX) - Seelos Therapeutics Inc. (SEEL) announced encouraging preclinical data from an in vivo study of SLS-005 (trehalose injection, 90.5 mg/mL for intravenous infusion) in an...
► Artikel lesen
25.09.SEELOS THERAPEUTICS, INC. - 8-K, Current Report3
22.09.Where Seelos Therapeutics Stands With Analysts9
21.09.Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session8
21.09.Seelos extends losses as Cantor downgrades after Phase 2 setback10
20.09.Why Is Depression Focused Seelos Therapeutics Stock Plunging Today?4
20.09.Seelos hits record low as experimental treatment for suicidal behavior fails in study8
20.09.Seelos Bruised on Test Results-
20.09.Seelos Therapeutics: SLS-002 Phase II Study Fails To Meet Primary Endpoint On Limited Sample Size313BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Seelos Therapeutics, Inc. (SEEL) reported top line data showing clinically meaningful treatment effects across multiple endpoints and a well-tolerated safety...
► Artikel lesen
20.09.Seelos plummets as Phase 2 trial for lead asset fails8
20.09.Seelos falls as experimental treatment for suicidal behavior fails in study9
20.09.SEELOS THERAPEUTICS, INC. - 8-K, Current Report2
15.09.Seelos Therapeutics files for common stock offering - filing3
14.09.SEELOS THERAPEUTICS, INC. - 8-K, Current Report2
22.08.4 Analysts Have This to Say About Seelos Therapeutics7
29.06.SEELOS THERAPEUTICS, INC. - 8-K, Current Report6
22.06.Seelos spikes as trial for lead asset completes enrollment9
30.05.Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving Premarket4
Seite:  Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1